Immunological memory is thought to depend on a stem cell-like, self-renewing population of lymphocytes capable of differentiating into effector cells in response to antigen re-exposure. Here we describe a long-lived human memory T cell population that has an enhanced capacity for self-renewal and a multipotent ability to derive central memory, effector memory and effector T cells. These cells, specific to multiple viral and self-tumor antigens, were found within a CD45RO − , CCR7 + , CD45RA + , CD62L + , CD27 + , CD28 + and IL-7Ra + T cell compartment characteristic of naive T cells. However, they expressed large amounts of CD95, IL-2Rb, CXCR3, and LFA-1, and showed numerous functional attributes distinctive of memory cells. Compared with known memory populations, these lymphocytes had increased proliferative capacity and more efficiently reconstituted immunodeficient hosts, and they mediated superior antitumor responses in a humanized mouse model. The identification of a human stem cell-like memory T cell population is of direct relevance to the design of vaccines and T cell therapies.
Long-lived self-renewing memory lymphocytes are a hallmark feature of the adaptive immune system in response to pathogens and tumors [1] [2] [3] . In organ systems, nonreplicating, terminally differentiated cells are continually replenished by the progeny of less-differentiated stem cells. Similarly, it has been suggested that memory cells might contain stem cell-like cells capable of repopulating fully differentiated effector lymphocytes in response to antigenic stimuli 4, 5 . Indeed, several characteristics of stem cells can be found to certain degrees in memory B and T cells, including selective transcriptional profiles 6 , the capacity for self-renewal and the multipotency to differentiate into progeny with diverse fates 4, 5 .
The memory T cell compartment is heterogeneous and has been conventionally divided into two subsets on the basis of the expression of the lymph node homing molecules CD62L and CCR7 (ref. 7) . Central memory T cells (T CM cells) highly express CD62L and CCR7 and were thought to be the stem cell-like memory subset, whereas CD62L − CCR7 − effector memory T cells (T EM cells) are considered to be committed progenitor cells that undergo terminal differentiation after a limited number of divisions 4, 5 . The recent identification in mice of a population of memory T cells with enhanced stem cell-like qualities compared with conventional T CM cells adds complexity to this dichotomous view 8, 9 . These memory T cells, which were designated memory stem T cells (T SCM cells), have a CD44 low CD62L high phenotype similar to that of naive T cells (T N cells), but they coexpress stem cell antigen-1 (Sca-1) and high levels of the antiapoptotic molecule B cell lymphoma 2 (Bcl-2), the β chain of the IL-2 and IL-15 receptor (IL-2Rβ), and the chemokine (C-X-C motif) receptor CXCR3 (refs. 8,9) . Whether a similar memory T cell population exists in humans is currently under intensive investigation 10 .
A human CD8 + memory T cell population has been described that shares phenotypic and functional characteristics with hematopoietic stem cells including the expression of the stem cell marker c-KIT and the ability to expel cellular toxins through the ATP-binding cassette (ABC)-superfamily multidrug efflux protein ABCB1 (ref. 11 ). However, recent data revealed that these cells are predominantly Vα7.2 + mucosal associated invariant T cells (MAITs) 12 . More recently, others have 13 speculated that CD4 dim CD8 bright T cells that highly express β-catenin, a molecule associated with the generation of mouse T SCM cells 9, 14 , represent human T SCM cells, but the definitive identification of human T SCM cells remains to be accomplished.
RESULTS

Identification of human T memory stem cells
We previously found that mouse T SCM cells can be generated effectively in vitro by triggering Wnt signaling during T cell priming using Wnt3A or inhibitors of glycogen synthase kinase-3β (GSK-3β) 9, 14, 15 .
We sought to use the same strategy to generate candidate human T SCM cells by activating CD45RO − CD62L + naive CD8 + T cells with α-CD3/CD28 beads in the presence of the GSK-3β inhibitor TWS119 ( Fig. 1a) . After 2 weeks, the majority of T cells cultured with TWS119 retained a CD45RO − CD62L + naive-like phenotype, whereas in the absence of GSK-3β inhibition, T cells uniformly upregulated the memory marker CD45RO (Fig. 1a) . To determine whether the CD45RO − CD62L + T cells generated in the presence of TWS119 were truly naive cells or had acquired memory traits, we did an extensive phenotypic analysis using established markers of T cell activation and differentiation (Fig. 1b) 16 . The vast majority of molecules (CD45RA, CCR7, CD27, IL-2Rα, IL-7Rα, CD69, 41BB, CCR5 and CD57) showed a similar expression pattern between T N cells and TWS119-generated naive-like T cells ( Fig. 1b) . However, the naive-like T cells expressed levels of CD95 and IL-2Rβ similar to those observed in conventional memory T cells ( Fig. 1b) . Thus, we hypothesized that the expression of CD95 and IL-2Rβ in otherwise phenotypically naive T cells could identify human T SCM cells.
To determine if candidate T SCM cells occur naturally, we used polychromatic flow cytometry (PFC) 17 . On the basis of previous data 17 , we used a highly stringent criterion of seven markers to accurately define T N cells. Notably, we found a CD95 + IL-2Rβ + subset in CD45RO − CCR7 + CD45RA + CD62L + CD27 + CD28 + IL-7Rα + naive-like CD8 + (Fig. 1c ) and CD4 + (Supplementary Fig. 1a ) T cells. In 29 healthy donors, these cells, referred to hereafter as T SCM cells, represented about 2-3% of all circulating CD8 + and CD4 + T lymphocytes ( Fig. 1d and Supplementary  Fig. 1b ). Further phenotypic analysis of T cell differentiation markers revealed that T SCM cells also expressed more BCL-2, LFA-1, CXCR3, CXCR4, and less CD38 and CD31 compared with T N cells ( Fig. 1e and Supplementary Fig. 1c) . Notably, T SCM cells expressed all of the core phenotypic markers (IL-2Rβ, BCL-2 and CXCR3) of their mouse counterparts 8, 9 with the exception of SCA-1, which does not have a human ortholog. These T cells were phenotypically different from the CD161 + , IL-18Rα + candidate T SCM cells recently described 11 and were not MAITs 12 (Supplementary Fig. 2) . Similarly to conventional memory T cells, we detected T SCM cells at low frequencies (<1%) in umbilical cord blood ( Supplementary Fig. 3 ). The phenotype of T SCM cells suggests a tropism for lymphatic tissues, but full anatomical characterization of T SCM -cell niches remains to be addressed.
T SCM cells possess attributes of conventional memory T cells
Because of the concomitant expression of numerous markers of naive T cells as well as key molecules of memory differentiation, it remained unclear whether T SCM cells were functionally naive or memory T cells. Naive T cells have high levels of T cell receptor (TCR) rearrangement excision circles (TRECs), which are diluted during clonal proliferation 18 . Like T CM and T EM cells, we found that T SCM cells had a low TREC content, indicating that they had undergone several rounds of division ( Fig. 2a ). Memory T cells can also be distinguished from T N cells by their ability to rapidly acquire effector functions upon antigen rechallenge 19 . We found that within 4 h after exposure to Staphylococcus enterotoxin B (SEB), a significant fraction of CD95 + naive-like CD8 + T cells produced IFN-γ, IL-2 and tumor necrosis factor (TNF)-α, whereas T N cells remained relatively quiescent (Fig. 2b,c) . Thus, T SCM cells rapidly acquired effector functions after superantigen stimulation similarly to conventional memory T cells ( Supplementary Fig. 4) . Notably, the fraction of responding cells, as well as T cell polyfunctionality, progressively increased from T N cells →T SCM cells →T CM cells →T EM cells ( Fig. 2c,d) , consistent with the hypothesis that T SCM cells are the least differentiated memory subset. We observed similar findings for CD4 + T cells ( Supplementary Fig. 1d,e ). We also observed the rapid responsiveness of T SCM cells after polyclonal stimulation with α-CD3/ CD2/CD28 beads ( Supplementary Fig. 5 ). Consistent with the intracellular cytokine staining result, we found that sorted T SCM cells, but not T N cells, secreted IFN-γ, IL-2 and TNF-α in response to α-CD3/CD2/CD28 stimulation ( Supplementary Fig. 6 ). Thus, T SCM cells possess the memory capability of rapid acquisition of effector functions after TCR stimulation.
Unlike T N cells, memory T cells undergo robust proliferation in the presence of the homeostatic cytokines IL-15 and IL-7 (refs. [20] [21] [22] . We found that, similarly to conventional CD8 + memory T cells, T SCM cells divided extensively in response to IL-15 ( Fig. 2e) . Although the majority of T EM cells proliferated ( Fig. 2f) , they underwent fewer divisions, revealing a lower proliferative potential compared with other memory subsets ( Fig. 2g) . By contrast, T SCM cells underwent numerous cell divisions ( Fig. 2g) , although the majority of these cells remained undivided ( Fig. 2f) . This behavior is reminiscent of stem cells, which are quiescent but can give rise to progeny capable of extensive proliferation and differentiation. We observed similar findings in the CD4 + T cell compartment in response to IL-7 ( Supplementary  Fig. 1f-h) . Thus, T SCM cells have the replicative history and ability to respond rapidly to antigenic and homeostatic stimuli, which are characteristics of memory T cells.
The frequency of naive CD8 + T cell precursors for a given epitope has been estimated to be between 6 × 10 −7 and 5 × 10 −6 , a range below the limit of peptide-major histocompatibility complex class I (pMHCI) tetramer detection 23 . We reasoned that if we could measure tetramer-binding, naive-like T cells, they would be enriched in the CD95 + T SCM cell compartment. In donors with detectable naive-like CD8 + T cells specific to influenza or cytomegalovirus (CMV) epitopes, the vast majority of tetramer-binding cells highly expressed CD95 (Fig. 2h,i and Supplementary  Fig. 7) . By contrast, virtually all MART-1 (melanoma antigen recognized by T cells)specific naive-like T cells in healthy donors did not express CD95, indicating that these cells were truly naive (Fig. 2h,i and Supplementary  Fig. 7) . Notably, we found that a significant fraction of MART-1specific CD8 + T cells had a CD95 + phenotype in 7 out of 11 subjects with metastatic melanoma (Fig. 2h,i and Supplementary  Fig. 7) . Thus, tetramer-binding T cells found in the naive-like T cell compartment could be derived from either increased thymic output (CD95 − ), as reported for MART-1 in healthy donors 24 , or from antigenic encounter, expansion and differentiation (CD95 + ). These experiments also revealed that T SCM cells represented a substantial fraction of the corresponding total antigen-specific CD8 + T cell memory responses, averaging 0.6% for CMV pp65 495-503 , 4.2% for influenza M1 58-66 and 7.6% for MART-1 [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , and that their frequency tended to correlate with that of conventional memory T cells (Supplementary Fig. 8 ).
To determine whether T SCM cell clonotypes represent a longlived population or merely recently activated cells transitioning from a naive to a conventional memory state, we analyzed TCR-β sequences of CMV-specific T cell subsets from the same donor spanning a time period of 22 months. Similarly to conventional memory T cells, we found dominant persisting clonotypes in T SCM cells, thereby indicating that they represent a stable memory T cell population ( Fig. 2j and Supplementary Table 1) . These findings show that T SCM cells are long-lived memory T cells with multiple viral-and self-tumor specificities.
T SCM cells represent the least differentiated T cell memory subset
We sought to compare the transcriptome of T SCM cells with naive and conventional memory T cell subsets and to validate key findings with PFC ( Fig. 3 and Supplementary Fig. 9 ). We found 900 differentially expressed genes among the four CD8 + T cell subsets (P < 0.01, false discovery rate <5%) ( Supplementary Table 2 ). Unsupervised hierarchical clustering revealed that T SCM cells had a distinct gene expression profile more closely related to that of conventional memory T cells than of T N cells, further corroborating the idea that T SCM cells are a unique T cell memory subset (Fig. 3a) . Consistent with previous findings 25 , the expression of the majority of genes (565 of 900) progressively increased (effector-associated genes) or decreased (naiveassociated genes) in the exact order: T N cells →T SCM cells →T CM cells →T EM cells ( Supplementary Table 3 ). Transcripts encoding key regulators of effector differentiation and senescence, such as eomesodermin 26 , T-box 21 (ref. 27 ) and PR domain-containing 1 with ZNF domain 28 , as well as cytotoxic molecules (for example, granzyme A and perforin) and markers of T cell senescence (for example, killer cell lectin-like receptor subfamily G, member 1, KLRG1) 27 , were increasingly expressed from T N cells to T EM cells (Fig. 3b) . Conversely, transcripts encoding transcription factors that inhibit T cell activation and differentiation, including lymphoid enhancer-binding factor 1 (ref. 9), forkhead box P1 (ref. 29 ) and LAG1 homolog, ceramide synthase 6, which promotes cellular quiescence by regulating intracellular ceramide levels 30 , progressively decreased from T N cells to T EM cells (Fig. 3b) . These data are consistent with a linear model of T cell differentiation, in which T SCM cells are the least differentiated memory T cell subset.
Multidimensional scaling (MDS) analysis 31 confirmed that T SCM cells comprised the memory T cell subset most similar to T N cells (Fig. 3c) . Indeed, we found that only 75 genes were differentially expressed between T N and T SCM cells (P < 0.01 and > twofold change in expression) compared with 157 and 226 for T CM and T EM cells, respectively ( Fig. 3c and Supplementary Tables 4-6 ). T SCM and T CM cells were the most closely related T cell subsets, with 20 differentially expressed genes (Fig. 3c,d and Supplementary Tables 4-9 ). Among these 
genes, T SCM cells, like T N cells, expressed low amounts of HNRPLL
(encoding heterogeneous nuclear ribonucleoprotein L-like), a key regulator of the alternative splicing of the CD45 pre-mRNA required for efficient CD45RO expression 32 , thus confirming the purity of the sorting. When we considered this subset of 20 genes, we found that T SCM cells had a pattern of expression similar to that of T N cells, whereas T CM cells clustered with T EM cells (Fig. 3d) , further underscoring the notion that T SCM cells are less differentiated than T CM cells.
Enhanced self-renewal and multipotency of T SCM cells
The abilities to self-renew and to differentiate into specialized cell types are defining qualities of stem cells. To determine whether T SCM have these stem cell-like properties, we evaluated their capacity to self-renew with homeostatic signals as well as their multipotency after TCR activation. After exposure to IL-15, the vast majority of T SCM cells maintained CD45RA + , and retained significantly (P < 0.05) higher amounts of CD62L and CCR7 than T CM cells ( Fig. 4a and Supplementary Fig. 10) . At the end of stimulation, about 60% of cells derived from T SCM maintained their phenotypic identity (CCR7 + CD62L + CD45RA + CD45RO − ), but only 30% of T CM cells retained their input phenotype (CCR7 + CD62L + CD45RA − CD45RO + ) (Fig. 4b) . T SCM cells also showed greater self-renewal capacity compared with T CM cells after a secondary exposure to IL-15 ( Supplementary Fig. 11) .
After α-CD3/CD2/CD28 stimulation, however, T SCM cells gradually upregulated CD45RO over several cell divisions while acutely downregulating CD62L and CCR7 ( Fig. 4c and Supplementary Fig. 10) . These dynamic changes in phenotype resulted in a diverse progeny, comprising about 50% of T CM cells and 4% of T EM cells (Fig. 4d) .
Most notably, 15% of T SCM -derived cells maintained a CCR7 + CD62L + CD45RA + CD45RO − phenotype even after this potent stimulus, thus indicating that T SCM cells have the multipotent capacity to derive all memory T cell subsets (Fig. 4d) . By contrast, we found that T CM cells retained a central memory phenotype or differentiated into T EM cells, but they did not generate T SCM cells (Fig. 4d) . Consistent with their advanced differentiation state, T EM cells did not reacquire CD62L or CCR7 and did not dedifferentiate into T CM or T SCM cells after either IL-15 or α-CD3/CD2/CD28 stimulation (Fig. 4a-d) . Taken together, these findings suggest that T SCM cells have the stem cell-like properties of self-renewal and multipotency in vitro (Fig. 4e) .
Increased proliferation, survival and antitumor activity of T SCM cells
We previously found that mouse T SCM cells have enhanced proliferative and survival capacities compared with T CM and T EM cells 9 . To evaluate the replicative responses of T SCM cells, we measured 3 H-thymidine incorporation after TCR stimulation. As previously reported 33 , T CM and T N cells showed increased proliferative responses compared with T EM cells, but they were outpaced by T SCM cells (Fig. 5a) . Although assessment of telomerase activity was uninformative ( Supplementary  Fig. 12) , we sought to ascertain the long-term replicative and survival capacities of T SCM cells. We adoptively transferred CD8 + T cell subsets into highly immunodeficient NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice and evaluated T cell engraftment 1 month after transfer. We co-transferred CD8-depleted peripheral blood mononuclear cells (PBMCs) to provide a source of human cytokines and co-stimulatory molecules 34 . We found that T SCM cells engrafted with 10-to 100-fold more progeny than T CM or T N cells in both lymphoid and nonlymphoid tissues (Fig. 5b,c and Supplementary Fig. 13) . Notably, T EM cells, which resemble cell populations used in current clinical trials for adoptive immunotherapy 35, 36 , had a poor proliferative and survival capability resulting in negligible engraftment 1 month after transfer (Fig. 5b,c and Supplementary Fig. 13) . This humanized mouse model, however, is inadequate to test T cell self-renewal in vivo because we found that all CD8 + T cell subsets uniformly differentiated into effector cells (Supplementary Fig. 14) , perhaps as a result of encounter with homeostatic cytokines and with xenogeneic major histocompatibility antigens. Nonetheless, adoptive transfer in NSG mice suggests that T SCM cells have enhanced replicative and survival capabilities compared with naive and conventional memory subsets.
T cell proliferative and survival capacities correlate with the antitumor efficacy of adoptively transferred T cells [35] [36] [37] [38] [39] . TCR or chimeric antigen receptor (CAR) gene engineering are currently used in the clinic to redirect the specificity of circulating T cells toward the desired target 36, 40, 41 . We exploited this approach, coupled to the pharmacological activation of Wnt signaling, to generate high numbers of mesothelin-specific ex vivo-generated memory T cell subsets (Supplementary Fig. 15 ) to test in a xenograft tumor model that we recently established 34 . Mesothelin-specific T SCM , T CM or T EM cells were co-transferred with mesothelin-specific CD4 + T cells into NSG mice bearing luciferase-expressing M108 mesothelioma established for 3 months in the peritoneum. To generate a treatment window, we administered 3 × 10 6 CD8 + T cells and 10 6 CD4 + T cells, about 10% of the previously described curative dose in this humanized tumor model 34 . T EM cells mediated poor antitumor responses, as indicated by the high intensity of the tumor-derived bioluminescent signal in the abdomen (Fig. 5d ) and the ascites-dependent weight gain (Fig. 5e) . Furthermore, the transfer of T EM cells did not significantly extend the survival of the mice compared with CD4 + T cells alone (Fig. 5f) . T CM cells were more effective than T EM cells but all mice died from tumor progression within 40 d after treatment ( Fig. 5d-f) . In contrast, T SCM cells triggered tumor regression and cure in mice that otherwise died within 2-3 weeks in the absence of CD8 + T cell transfer ( Fig. 5d-f) . We ascribed the late mortality of mice receiving T SCM cells to the development of xenogeneic graft-versus-host disease, as manifested by loss of body weight (Fig. 5d,e) . Thus, we suggest that adoptively transferred T SCM cells have enhanced antitumor activity and are more therapeutically effective than conventional T CM and T EM cells in mice.
DISCUSSION
We identified a long-lived human memory T cell subset found within the naive-like T cell compartment. Once thought to be homogenous, the so-called 'naive T cell subset' is emerging as a complex amalgamation of cell types, including recent thymic emigrants 42, 43 , 'supernaive' CD44 very low T cells 44 , and CXCR3 + or CCR4 + early memory cells 45 . Evidence presented here suggests that T SCM cells are a clonally expanded primordial memory subset arising after antigenic stimulation with increased proliferative and reconstitutive capacities. T SCM cells have an enhanced self-renewal capacity and the multipotency to generate all memory and effector T cell subsets in vitro. These qualities are all consistent with stem cell-like behavior, but formal proof of 'stemness' in vivo will have to await clinical trials involving the adoptive transfer of T SCM cells and assessment of long-term self-renewal and repopulating potential. Nevertheless, the qualities of human T SCM cells that we have measured are consistent with those of mouse T SCM cells that showed enhanced self-renewal and multipotency in serial transplantation experiments 8,9 . Given the young age, relative to life expectancy, at which the thymus involutes in humans, the presence of such a long-lived, lessdifferentiated memory T cell population might ensure protection against pathogens throughout life. Indeed, the vast majority of naive-like T cells in centenarians highly express CD95 (ref. 46 ), a phenotype consistent with the T SCM cells described here. Expression of CD95 by long-lived memory T cells might seem perplexing because of its well-established proapoptotic function. However, the outcome of Fas ligand-CD95 interaction might be dependent on the differentiation state of the cellular substrate, as observed in other organ systems 47 . CD95 triggers apoptosis in terminally differentiated neurons through the formation of a death-inducing complex, but it promotes cell proliferation in neural progenitors and cancer stem cells by inducing T cell factor (TCF)-β-catenin signaling 47 . Considering the emerging role of TCF-β-catenin signaling in the formation and maintenance of memory T cells 9, 14, 48, 49 , CD95 might demarcate memory T cells and be functionally important for their self-renewal and persistence.
The finding that T SCM cells have enhanced proliferative capacity and can sustain the generation of all memory and effector T cell subsets has considerable implications for the design of T cell-based vaccines to target intracellular pathogens and cancer. Heterologous prime-boost approaches have been used to increase the frequency of memory T cells, but they have the undesired effect of driving T cells toward a state of terminal differentiation 3,50,51 , which compromises their ability to clear systemic infections 52, 53 and eradicate tumors 37 . The use of small molecules targeting the mTOR 54, 55 and Wnt 14, 56 signaling pathways might improve vaccines by modulating T cell differentiation and enriching for T SCM and T CM cells. Finally, by coupling TCR or CAR gene-engineering technology 36, 40, 41 with the pharmacologic modulation of T cell differentiation 56 , we have demonstrated a feasible and translatable strategy for the in vitro generation of highly effective T SCM -like cells to use in adoptive T cell therapy trials for the treatment of cancer and infectious diseases.
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